About Ribo
Science
Pipeline
Collaboration
Investors
Careers
About Ribo
International R&D Center
Scientific Advisory Board
Our Culture
News
About Oligonucleotide Therapeutics
Technological Innovations
Intellectual Property
Pipeline
Products
Clinical Trials
BD and Collaboration
Overview
Our Culture
Career Development
Recruitment
CN
B3-pcbanner.jpg B3-phbanner.jpg
News
About RiboNews
Ribo was selected as one of 2019 "Most Innovative Pharmaceutical Companies in Asia" by Clarivate Analytics
Sep 03,2019
Last : Ribo completed the enrollment of the first patient into the Chinese phase II clinical trial on ASOISIS449884 Injection
Next : Ribo's clinical application for new oligonucleotide therapeutics in the treatment of type 2 diabetes got approved